Efficacy, Safety And Tolerability Of 3 Day Azithromycin Versus 10 Day Co

In particular, studies have been limited in their ability to control for key confounders, such as indication for use. An a priori subgroup analysis quantified the effects of azithromycin exposure among patients with increased baseline cardiovascular risk. The secondary outcomes were noncardiovascular death and all-cause mortality. In any way follow-up visits, adverse events, use of… Continue reading Efficacy, Safety And Tolerability Of 3 Day Azithromycin Versus 10 Day Co